Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,849,947 | 0 | 26,602 | 39,459 | 19.94% | +12,857 |
| Kinnate Biopharma Inc. | 9,671,643 | 9,671,643 | 0 | 22,922 | 25,727 | 13.00% | +2,805 |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | 16,151 | 18,565 | 9.38% | +2,414 |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 875,000 | 0 | 18,909 | 20,825 | 10.52% | +1,916 |
| Pharvaris N.V. COM | 4,038,842 | 4,038,842 | 0 | 113,290 | 93,338 | 47.16% | -19,952 |